Replies to post #114545 on Biotech Values

[HattieTheWitch]

(me) I was under the impression that the FDA reached out in general, not specifically to MNTA.

Am I wrong?

(mcbio) sodrock is presumably referring to who the FDA reached out to in order to help it solve the heparin contamination crisis.

Yes, I know the FDA reached out, but my impression was that MNTA was not *the* company that was reached out to, and in reading sodrock's post, I believe that's what he suggested.

His post:

...It is not a coincidence that the FDA sought out MNTA and their scientists to help with the Baxter heparin contamination issues in 2008.

Lets think about this for a second. The FDA reaches out to a company that has NO approved products on the market and only an ANDA for m-enox. What was the reason for this? They had a hunch? Or did they recognize their ability in that area?

sodrock?